{"entryType":"UniProtKB reviewed (Swiss-Prot)","primaryAccession":"P05230","features":[{"type":"Natural variant","location":{"start":{"value":21,"modifier":"EXACT"},"end":{"value":21,"modifier":"EXACT"}},"description":"in dbSNP:rs17223632","featureCrossReferences":[{"database":"dbSNP","id":"rs17223632"}],"evidences":[{"evidenceCode":"ECO:0000269","source":"Reference","id":"Ref.8"}],"featureId":"VAR_021357","alternativeSequence":{"originalSequence":"G","alternativeSequences":["E"]}},{"type":"Mutagenesis","location":{"start":{"value":24,"modifier":"EXACT"},"end":{"value":27,"modifier":"EXACT"}},"description":"Loss of nuclear import leading to loss of phosphorylation by PKC/PRKCD.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"22321063"}],"alternativeSequence":{"originalSequence":"KKPK","alternativeSequences":["AAPA"]}},{"type":"Mutagenesis","location":{"start":{"value":33,"modifier":"EXACT"},"end":{"value":33,"modifier":"EXACT"}},"description":"No effect on integrin-binding.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"}],"alternativeSequence":{"originalSequence":"N","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":50,"modifier":"EXACT"},"end":{"value":50,"modifier":"EXACT"}},"description":"Dominant-negative mutant. Defective in integrin-binding and in ternary complex formation with integrin and FGFR1. No effect on heparin- and FGFR1-binding. Defective in inducing FGF1 signaling, cell proliferation and cell migration. Defective in inducing angiogenesis, and suppression of angiogenesis in different in vitro and in vivo angiogenesis models.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"20422052"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"23469107"}],"alternativeSequence":{"originalSequence":"R","alternativeSequences":["E"]}},{"type":"Mutagenesis","location":{"start":{"value":102,"modifier":"EXACT"},"end":{"value":102,"modifier":"EXACT"}},"description":"No effect on integrin-binding. No effect on integrin- and heparin-binding, loss of FGFR1-binding, defective in inducing FGF1 signaling, cell proliferation and cell migration; when associated with A-109 and A-110.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"}],"alternativeSequence":{"originalSequence":"E","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":109,"modifier":"EXACT"},"end":{"value":109,"modifier":"EXACT"}},"description":"No effect on integrin- and heparin-binding, loss of FGFR1-binding, defective in inducing FGF1 signaling, cell proliferation and cell migration; when associated with A-102 and A-110.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"}],"alternativeSequence":{"originalSequence":"Y","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":110,"modifier":"EXACT"},"end":{"value":110,"modifier":"EXACT"}},"description":"No effect on integrin-binding. No effect on integrin- and heparin-binding, loss of FGFR1-binding, defective in inducing FGF1 signaling, cell proliferation and cell migration; when associated with A-102 and A-109.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"}],"alternativeSequence":{"originalSequence":"N","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":114,"modifier":"EXACT"},"end":{"value":114,"modifier":"EXACT"}},"description":"Decrease in LRRC59-binding.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11964394"}],"alternativeSequence":{"originalSequence":"S","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":127,"modifier":"EXACT"},"end":{"value":127,"modifier":"EXACT"}},"description":"Reduced integrin-binding; when associated with E-128. Defective in integrin-, heparin- and FGFR1-binding, and defective in inducing FGF1 signaling, cell proliferation and cell migration; when associated with E-128; E-133 and E-134.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"}],"alternativeSequence":{"originalSequence":"K","alternativeSequences":["E"]}},{"type":"Mutagenesis","location":{"start":{"value":128,"modifier":"EXACT"},"end":{"value":128,"modifier":"EXACT"}},"description":"Reduced integrin-binding; when associated with E-127. Defective in integrin-, heparin- and FGFR1-binding, and defective in inducing FGF1 signaling, cell proliferation and cell migration; when associated with E-127; E-133 and E-134.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"}],"alternativeSequence":{"originalSequence":"K","alternativeSequences":["E"]}},{"type":"Mutagenesis","location":{"start":{"value":131,"modifier":"EXACT"},"end":{"value":131,"modifier":"EXACT"}},"description":"Decrease in LRRC59-binding.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11964394"}],"alternativeSequence":{"originalSequence":"S","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":131,"modifier":"EXACT"},"end":{"value":131,"modifier":"EXACT"}},"description":"Decrease in LRRC59-binding.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11964394"}],"alternativeSequence":{"originalSequence":"S","alternativeSequences":["E"]}},{"type":"Mutagenesis","location":{"start":{"value":133,"modifier":"EXACT"},"end":{"value":133,"modifier":"EXACT"}},"description":"Loss of LRRC59-binding.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11964394"}],"alternativeSequence":{"originalSequence":"K","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":133,"modifier":"EXACT"},"end":{"value":133,"modifier":"EXACT"}},"description":"Loss of CSNK2A-, CSNK2B- and LRRC59-binding. Reduced integrin-binding; when associated with E-134. Defective in integrin-, heparin- and FGFR1-binding, and defective in inducing FGF1 signaling, cell proliferation and cell migration; when associated with E-128; E-133 and E-134.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11964394"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"}],"alternativeSequence":{"originalSequence":"K","alternativeSequences":["E"]}},{"type":"Mutagenesis","location":{"start":{"value":133,"modifier":"EXACT"},"end":{"value":133,"modifier":"EXACT"}},"description":"No effect on LRRC59-binding.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11964394"}],"alternativeSequence":{"originalSequence":"K","alternativeSequences":["R"]}},{"type":"Mutagenesis","location":{"start":{"value":134,"modifier":"EXACT"},"end":{"value":134,"modifier":"EXACT"}},"description":"Reduced integrin-binding; when associated with E-133. Defective in integrin-, heparin- and FGFR1-binding, and defective in inducing FGF1 signaling, cell proliferation and cell migration; when associated with E-127; E-128 and E-133.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18441324"}],"alternativeSequence":{"originalSequence":"R","alternativeSequences":["E"]}}],"extraAttributes":{"uniParcId":"UPI00000411BE"}}